|
Subject#
|
Treatment type
|
ALT (U/L) baseline
|
ALT (U/L) peak
|
Peak ALT(ULN)
|
AST (ULN)
|
ALP (ULN)
|
Total bilirubin (ULN)
|
|---|
|
1
|
Placebo
|
16
|
273
|
6.1
|
1.8
|
1.0
|
0.6
|
|
2
|
Placebo
|
19
|
320
|
9.4
|
3.6
|
0.7
|
0.4
|
|
3
|
Placebo
|
15
|
967
|
28.4
|
10.9
|
0.9
|
0.6
|
|
4
|
Placebo
|
18
|
119
|
3.5
|
1.9
|
0.7
|
0.5
|
|
5
|
Placebo
|
16
|
145
|
4.3
|
2.6
|
0.6
|
0.8
|
|
6
|
Placebo
|
12
|
146
|
4.3
|
2.6
|
0.6
|
0.4
|
|
7
|
Moxifloxacin
|
33
|
164
|
3.6
|
1.8
|
1.1
|
0.3
|
|
8
|
Moxifloxacin
|
32
|
173
|
3.8
|
2.0
|
0.6
|
0.5
|
|
9
|
Moxifloxacin
|
30
|
229
|
5.1
|
2.7
|
1.4
|
0.9
|
|
10
|
Moxifloxacin
|
14
|
142
|
3.2
|
1.5
|
0.7
|
0.9
|
|
11
|
Moxifloxacin
|
20
|
136
|
4.0
|
1.9
|
0.8
|
0.4
|
- For ALT, both absolute peak value and ULN have been included. For AST, ALP, and total Bilirubin only ULN have been included.
